AGP Executive Report
Last update: 10 hours agoInnovative Drug Access: Czech patients are facing longer waits for innovative medicines, with average access time rising to 659 days and the share of new therapies available to patients dropping to 50%, according to EFPIA’s Patients W.A.I.T. Indicator 2025. EU Oversight: The European Commission has launched infringement procedures against 20 EU countries, including Czechia, for failing to fully transpose EU rules on empowering consumers for the green transition, with formal notice letters giving two months to respond. Ebola Response (Global Health): The U.S. confirmed a 50-bed Ebola quarantine facility in Kenya will open Friday for Americans exposed in the DRC, with plans to send symptomatic patients to third countries rather than back to the U.S. Public Health Policy (Global): WHO is warning of rapidly rising Ebola risk in Congo, as the outbreak expands and health systems struggle amid insecurity. Wellness Trend (Czech Link): A Czech-style beer spa tradition is being brought to the U.S., highlighting wort-based treatments popular in Prague and other Czech cities.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Czech patients face longer waits for innovative drugs as access slips [Advocacy Lab]](https://www.euractiv.com/content/uploads/sites/2/2026/05/GettyImages-1608041378.jpg)
